Skip to main content
Focused investors/David Abrams

David Abrams - Abrams Capital Management

As of Q2 2026, David Abrams reported 11 long-equity positions worth $5.48B in aggregate.

Copy-investor backtest

Latest quarter
+13.81%
1-year
+10.15%
3-year
+40.27%
5-year
+47.83%
3-year vs S&P 500
-32.79%
5-year vs S&P 500
-26.07%
5-year top 5
+36.63%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when David Abrams files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 5 of 13 rows. Rows without a quote are marked unavailable.

1HRBBLOCK H & R INC COM16.85%New10,180,498$170.42M$16.74No quote
2SLMSLM CORP COM14.97%-9,896,207$151.41M$15.30No quote
3QVCALIBERTY MEDIA CORP NEW INT COM SER A12.81%-8,074,750$129.52MNo quoteNo quote
4ARBARBITRON INC COM11.75%Reduce -16.7%2,967,775$118.8MNo quoteNo quote
5CCICROWN CASTLE INTL CORP COM11.35%-2,697,983$114.8M$42.55No quote
6LZLUBRIZOL CORP COM7.95%New600,000$80.38M$133.96No quote
7IRMIRON MTN INC COM6.18%New2,000,000$62.46MNo quoteNo quote
8MHPMCGRAW HILL COS INC COM5.93%-1,522,146$59.97MNo quoteNo quote
9CCOCLEAR CHANNEL OUTDOOR HLDGS CL A4.77%-3,317,090$48.26M$14.55No quote
10CFNCAREFUSION CORP COM4.74%-1,700,000$47.94MNo quoteNo quote
11PMTPENNYMAC MTG INVT TR COM2.08%-1,143,600$21.03MNo quoteNo quote
12TEVA 0.25 02/01/26 CTEVA PHARMACEUTICAL FIN LLC DBCV 0.250% 2/0CUSIP 88163VAE90.62%New5,500,000$6.29MNo quoteNo quote
13CFFNCAPITOL FED FINL COM-Sold0$0No quoteNo quote